Prudential Financial’s Theravance Biopharma TBPH Stock Holding History

Prudential Financial’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$843K	Sell	49,605 -45,510	-48%	-$753K	﹤0.01%	1716
2026 Q1	$1.54M	Buy	95,115 +78,450	+471%	+$1.39M	﹤0.01%	1431
2025 Q4	$312K	Buy	+16,665	New	+$276K	﹤0.01%	1969
2025 Q2	–	Sell	-10,140	Closed	-$90.5K	–	2511
2025 Q1	$90.5K	Buy	+10,140	New	+$94.4K	﹤0.01%	2138
2024 Q4	–	Sell	-57,240	Closed	-$461K	–	2684
2024 Q3	$461K	Buy	+57,240	New	+$496K	﹤0.01%	2250
2023 Q4	–	Sell	-16,505	Closed	-$142K	–	2715
2023 Q3	$142K	Sell	16,505 -4,680	-22%	-$45.2K	﹤0.01%	2424
2023 Q2	$219K	Buy	21,185 +5,400	+34%	+$59.6K	﹤0.01%	2412
2023 Q1	$171K	Buy	+15,785	New	+$167K	﹤0.01%	2419
2019 Q1	–	Sell	-9,270	Closed	-$237K	–	2467
2018 Q4	$237K	Sell	9,270 -40	-0.4%	-$1.08K	﹤0.01%	2196
2018 Q3	$304K	Sell	9,310 -140	-1%	-$3.82K	﹤0.01%	2195
2018 Q2	$214K	Buy	+9,450	New	+$224K	﹤0.01%	2328

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

ICM

Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Prudential Financial's TBPH Position: Q2 2026 in Review

Prudential Financial reduced its Theravance Biopharma (TBPH) stake by 48% in Q2 2026, selling an estimated $753K and leaving 49,605 shares worth $843K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Prudential Financial first reported a position in TBPH in Q2 2018 and has held it in 11 quarters since. The position peaked at $1.54M in Q1 2026. 181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

Prudential Financial held 49,605 shares of Theravance Biopharma worth $843K as of Q2 2026.
Prudential Financial sold 45,510 Theravance Biopharma shares in Q2 2026, an estimated $753K.
Theravance Biopharma made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1716 holding.
Prudential Financial first reported a position in Theravance Biopharma in Q2 2018 and has held it in 11 quarters since.
Prudential Financial's Theravance Biopharma position peaked at $1.54M in Q1 2026.
181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.